Skip to main content Skip to main navigation menu Skip to site footer

Serum ferritin level in pediatric patients with acute lymphoblastic leukemia (ALL) in the early stage of diagnosis and remission phase

  • Novia ,
  • Nelly Rosdiana ,
  • Supriatmo ,


Abstract

Background: Cancer cells increase iron absorption, interfere with iron storage, and reduce iron excretion. Acute lymphoblastic leukemia (ALL) condition may interfere with the iron synthesis, and the patients usually receive a blood transfusion which leads to iron buildup. Excess iron is linked to a poor prognosis and significantly becomes morbidity and mortality factors. Serum ferritin levels that can be assessed from complete blood count may become a low-cost and sensitive biomarker and prognostic marker for ALL. The aim of this research is to assess serum ferritin levels in pediatric patients with ALL in the diagnosis and remission phases.

Methods: An analytical observational cross-sectional study was conducted on pediatric patients with ALL in the pediatric ward Haji Adam Malik hospital Medan from July – October 2021. Physical examination and blood sampling for complete blood count and serum ferritin level assessment were carried out. Bivariate analysis using the Chi-square test was used to compare serum ferritin levels during early diagnosis and remission phases in ALL pediatric patients.

Results: Ferritin levels were higher in the newly diagnosed patient group with a median value of 951 µg/L (28.07-6632 µg/L) than the group in remission phase with a median value of 374.5 µg/L (29-2426 µg/L). There were no significant relationships between ferritin levels and BMI, SGOT, and SGPT in the newly diagnosed group. In contrast, the ferritin levels of the patients in the remission group were significantly correlated with SGOT and SGPT.

Keywords: acute lymphoblastic leukemia cancer remission phase serum ferritin level

References

  1. Namayandeh SM, Khazaei Z, Lari Najafi M, Goodarzi E, Moslem A. GLOBAL Leukemia in Children 0-14 Statistics 2018, Incidence and Mortality and Human Development Index (HDI): GLOBOCAN Sources and Methods. Asian Pac J Cancer Prev. 2020;21(5):1487-1494. Published 2020 May 1. doi:10.31557/APJCP.2020.21.5.1487.
  2. Davis AS, Viera AJ, Mead MD. Leukemia: an overview for primary care. Am Fam Physician. 2014;89(9):731-738.
  3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34. doi:10.3322/caac.21551.
  4. Hamad MNM, Kamal M, Saeed MA, Suliman MA. Assessment of Serum Ferritin Levels in Sudanese Patients with Acute Lymphoblastic Leukemia. Int J Med Res Health Sci. 2019;8. p92-6.
  5. Brown RAM, Richardson KL, Kabir TD, Trinder D, Ganss R, Leedman PJ. Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology. Front Oncol. 2020;10:476. Published 2020 Apr 9. doi:10.3389/fonc.2020.00476.
  6. Prieto-Bermejo R, Romo-González M, Pérez-Fernández A, Ijurko C, Hernández-Hernández Á. Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side. J Exp Clin Cancer Res. 2018;37(1):125. Published 2018 Jun 26. doi:10.1186/s13046-018-0797-0.
  7. Fonseca-Nunes A, Jakszyn P, Agudo A. Iron and cancer risk--a systematic review and meta-analysis of the epidemiological evidence. Cancer Epidemiol Biomarkers Prev. 2014;23(1):12-31. doi:10.1158/1055-9965.EPI-13-0733.
  8. Rassool FV, Gaymes TJ, Omidvar N, et al. Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia?. Cancer Res. 2007;67(18):8762-8771. doi:10.1158/0008-5472.CAN-06-4807.
  9. Manz DH, Blanchette NL, Paul BT, Torti FM, Torti SV. Iron and cancer: recent insights. Ann N Y Acad Sci. 2016;1368(1):149-161. doi:10.1111/nyas.13008.
  10. Leggett BA, Brown NN, Bryant SJ, Duplock L, Powell LW, Halliday JW. Factors affecting the concentrations of ferritin in serum in a healthy Australian population. Clin Chem. 1990;36(7):1350-1355.
  11. McKinnon EJ, Rossi E, Beilby JP, Trinder D, Olynyk JK. Factors that affect serum levels of ferritin in Australian adults and implications for follow-up. Clin Gastroenterol Hepatol. 2014;12(1):101-108.e4. doi:10.1016/j.cgh.2013.07.019.
  12. Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: Past, present and future. Biochim Biophys Acta. 2010;1800(8):760-769. doi:10.1016/j.bbagen.2010.03.011.
  13. VanWagner LB, Green RM. Elevated serum ferritin. JAMA. 2014;312(7):743-744. doi:10.1001/jama.2014.302.
  14. Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol. 2017;29(9):401-409. doi:10.1093/intimm/dxx031.
  15. Liu Y, Wang B, Liu X, Xie X, Gu W, Li H, et al. Clinical variations of serum levels of ferritin, folic and vitamin B12 in acute leukemia patients. J Med Coll PLA. 2011;26:264–70. https://doi.org/10.1016/S1000-1948(11)60051-8.
  16. Armand P, Kim HT, Cutler CS, et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood. 2007;109(10):4586-4588. doi:10.1182/blood-2006-10-054924.
  17. Ragab S, Safan M, Tayel S, Genena S, Ghanayem N. Serum hepcidin level evaluation in children with acute lymphoblastic leukemia during different treatment phases; the influence of erythroid activity and iron stores. Clin Cancer Investig J. 2016;5(1):25-31. https://doi.org/10.4103/2278-0513.172035.
  18. Pattnaik J, Kayal S, Dubashi B, et al. Profile of anemia in acute lymphoblastic leukemia patients on maintenance therapy and the effect of micronutrient supplementation. Support Care Cancer. 2020;28(2):731-738. doi:10.1007/s00520-019-04862-6.
  19. Bourisly M, Bourhama M, Obaid MA. Iron overload with Leukemia: Experience of The Only Departement of Pediatric Hematology Oncology in Kuwait. Medical Research Archives. 2017;5(3). p1-14.
  20. Hamodat ZMA, AL-Talib NA, Abduljalal MH. Study of some biochemical markers for patients with leukemia. EurAsian J Biosci. 2020;6. p1315-1320.
  21. Gaynon PS. Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol. 2005;131(5):579-587. doi:10.1111/j.1365-2141.2005.05773.x.
  22. Tachibana T, Andou T, Tanaka M, et al. Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective Study. Clin Lymphoma Myeloma Leuk. 2018;18(6):415-421. doi:10.1016/j.clml.2018.03.009.
  23. Moafi A, Ziaie M, Abedi M, et al. The relationship between iron bone marrow stores and response to treatment in pediatric acute lymphoblastic leukemia. Medicine (Baltimore). 2017;96(44):e8511. doi:10.1097/MD.0000000000008511.
  24. Altès A, Remacha AF, Sureda A, et al. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29(12):987-989. doi:10.1038/sj.bmt.1703570.
  25. Cacciotti C, Athale U. Transfusion-related Iron Overload in Children With Leukemia. J Pediatr Hematol Oncol. 2021;43(1):18-23. doi:10.1097/MPH.0000000000001849.

How to Cite

Novia, Rosdiana, N. ., & Supriatmo. (2022). Serum ferritin level in pediatric patients with acute lymphoblastic leukemia (ALL) in the early stage of diagnosis and remission phase. Bali Medical Journal, 11(3), 1598–1602. https://doi.org/10.15562/bmj.v11i3.3595
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
0

Total
0

Share